• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov24
Avidity Biosciences Inc. Special Shareholder Meeting to Vote on Novartis Merger Agreement
22:11
Nov19
Avidity Biosciences Announces Management Access Program for DMD Patients
14:14
Nov14
FactSet analysts lower 2025 EPS forecast for Avidity Biosciences Inc
12:22
Nov11
RBC Capital analyst reiterates hold rating on Avidity Biosciences
12:32
Avidity Biosciences released FY2025 9 Months Earnings on November 10 (EST), with actual revenue of USD 17.9 M and EPS of USD -3.3836
04:00
Avidity Biosciences released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 12.48 M (forecast USD 1.808 M), actual EPS USD -1.265 (forecast USD -1.1058)
04:00

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 12.48 M, Net Income -174.44 M, EPS -1.265

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.847 M, Net Income -157.32 M, EPS -1.2136

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.573 M, Net Income -115.77 M, EPS -0.9

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More